Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $8.0000 (-4.19%) ($8.0000 - $8.0000) on Thu. Apr. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 41.93% (three month average) | RSI | 21 | Latest Price | $8.0000(-4.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -1.9% a day on average for past five trading days. | Weekly Trend | EYES declines -24.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) FXI(36%) IBUY(19%) IWC(18%) IPO(17%) PEJ(17%) | Factors Impacting EYES price | EYES will decline at least -20.965% in a week (0% probabilities). TIP(-43%) VCIT(-37%) TLT(-37%) HYG(-27%) IGOV(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -20.965% (StdDev 41.93%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.15 | 5 Day Moving Average | $8.27(-3.26%) | 10 Day Moving Average | $9.57(-16.41%) | 20 Day Moving Average | $11.15(-28.25%) | To recent high | -48.3% | To recent low | 38.2% | Market Cap | $2.555b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |